Lanthionine Synthetase Component C-Like Protein 2: A New Drug Target for Inflammatory Diseases and Diabetes

E-ISSN： 1873-5592|15|6|565-572

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.6, 2014-06, pp. : 565-572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

By McCluskey A. Ackland1 S.P. Gardiner E. Walkom C.C. Sakoff1 J.A.

Anti-Cancer Drug Design, Vol. 16, Iss. 6, 2001-12 ,pp. : 291-303

Cognizant Communication Corporation

Access to resources Recommend Favorite

The Prokaryotic FAD Synthetase Family: A Potential Drug Target

Current Pharmaceutical Design, Vol. 19, Iss. 14, 2013-04 ,pp. : 2637-2648

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy

Current Neuropharmacology, Vol. 11, Iss. 1, 2013-01 ,pp. : 114-127

Bentham Science Publishers

Access to resources Recommend Favorite

GPR40 Carboxylic Acid Receptor Family and Diabetes: A New Drug Target

Current Drug Targets, Vol. 9, Iss. 10, 2008-10 ,pp. : 899-910

Bentham Science Publishers

Access to resources Recommend Favorite